LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1,005.00%221M | -39.98%695M | -20.93%340M | -46.63%182M | -26.79%153M | -88.76%20M | 47.33%1.16B | 28.36%430M | 48.91%341M | 15.47%209M |
Net income from continuing operations | 312.00%103M | 81.37%292M | 22.10%221M | 76.08%-50M | -5.88%96M | -71.26%25M | -65.82%161M | 74.04%181M | -237.50%-209M | 41.67%102M |
Operating gains losses | --112M | --409M | --0 | --238M | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | -11.48%54M | -0.42%235M | -4.84%59M | -3.33%58M | -1.72%57M | 8.93%61M | 5.36%236M | 8.77%62M | 5.26%60M | 5.45%58M |
Deferred tax | 80.00%-1M | 32.89%-100M | 196.30%26M | 42.11%-66M | -1,733.33%-55M | 0.00%-5M | -3,080.00%-149M | -350.00%-27M | -2,380.00%-114M | -175.00%-3M |
Other non cash items | -600.00%-5M | -31.58%26M | 100.00%8M | 433.33%10M | -66.67%7M | -93.75%1M | 100.00%38M | -66.67%4M | 72.73%-3M | 110.00%21M |
Change In working capital | 26.67%-55M | -168.08%-241M | -96.45%7M | -125.56%-34M | -1,490.00%-139M | -635.71%-75M | 457.58%354M | 328.26%197M | 1,800.00%133M | -58.33%10M |
-Change in receivables | -22.22%84M | -161.54%-34M | -50.00%-18M | 60.76%-31M | -720.00%-93M | 71.43%108M | 84.52%-13M | 57.14%-12M | 9.20%-79M | -82.14%15M |
-Change in inventory | 57.14%-6M | -5.17%55M | -22.22%35M | -675.00%-23M | 280.00%57M | -133.33%-14M | 422.22%58M | 28.57%45M | -78.95%4M | 142.86%15M |
-Change in prepaid assets | -72.73%-38M | 2,600.00%25M | -7.14%13M | 300.00%32M | -71.43%2M | 26.67%-22M | -106.25%-1M | 0.00%14M | 100.00%8M | -41.67%7M |
-Change in payables and accrued expense | 0.72%-137M | -189.17%-140M | -125.32%-20M | -67.42%43M | 3.85%-25M | -392.86%-138M | 434.04%157M | 71.74%79M | 780.00%132M | -116.67%-26M |
-Change in other working capital | 566.67%42M | -196.08%-147M | -104.23%-3M | -180.88%-55M | -7,900.00%-80M | -160.00%-9M | 350.00%153M | 438.10%71M | --68M | ---1M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1,005.00%221M | -39.98%695M | -20.93%340M | -46.63%182M | -26.79%153M | -88.76%20M | 47.33%1.16B | 28.36%430M | 48.91%341M | 15.47%209M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 486.96%89M | 21.52%-175M | 0.00%-81M | 30.91%-38M | 21.43%-33M | 48.89%-23M | 2.62%-223M | -30.65%-81M | 0.00%-55M | 25.00%-42M |
Capital expenditure reported | -62.50%-39M | 7.02%-212M | 3.57%-81M | 1.79%-55M | -23.81%-52M | 47.83%-24M | 9.16%-228M | -6.33%-84M | 11.11%-56M | 26.32%-42M |
Net business purchase and sale | --128M | --17M | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other investing changes | ---- | 300.00%20M | --0 | --0 | --19M | 0.00%1M | -77.27%5M | -82.35%3M | -87.50%1M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 486.96%89M | 21.52%-175M | 0.00%-81M | 30.91%-38M | 21.43%-33M | 48.89%-23M | 2.62%-223M | -30.65%-81M | 0.00%-55M | 25.00%-42M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -252.90%-237M | 13.01%-655M | -20.26%-273M | -31.75%-278M | 7.50%-259M | 542.86%155M | -9.29%-753M | 30.37%-227M | -64.84%-211M | -95.80%-280M |
Net issuance payments of debt | --0 | 76.06%-45M | -19.10%-106M | -88.73%-134M | 25.90%-103M | 168.47%298M | -126.51%-188M | 50.00%-89M | -691.67%-71M | -4,533.33%-139M |
Net common stock issuance | ---107M | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Cash dividends paid | -1.34%-151M | -2.06%-595M | -2.05%-149M | -1.37%-148M | -2.05%-149M | -2.76%-149M | -2.10%-583M | -2.10%-146M | -2.10%-146M | -2.10%-146M |
Proceeds from stock option exercised by employees | 250.00%21M | -96.97%1M | -108.70%-2M | -33.33%4M | -240.00%-7M | 700.00%6M | 560.00%33M | 360.00%23M | 100.00%6M | -37.50%5M |
Net other financing activities | ---- | -6.67%-16M | ---- | ---- | ---- | ---- | 0.00%-15M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -252.90%-237M | 13.01%-655M | -20.26%-273M | -31.75%-278M | 7.50%-259M | 542.86%155M | -9.29%-753M | 30.37%-227M | -64.84%-211M | -95.80%-280M |
Net cash flow | ||||||||||
Beginning cash position | -43.75%207M | 97.85%368M | -10.16%221M | 110.59%358M | 85.71%520M | 97.85%368M | -42.59%186M | 1.23%246M | -13.27%170M | 30.84%280M |
Current changes in cash | -51.97%73M | -174.18%-135M | -111.48%-14M | -278.67%-134M | -23.01%-139M | 55.10%152M | 237.88%182M | 330.19%122M | 63.04%75M | -527.78%-113M |
Effect of exchange rate changes | --2M | ---26M | --0 | -400.00%-3M | -866.67%-23M | --0 | --0 | --0 | 0.00%1M | --3M |
End cash Position | -45.77%282M | -43.75%207M | -43.75%207M | -10.16%221M | 110.59%358M | 85.71%520M | 97.85%368M | 97.85%368M | 1.23%246M | -13.27%170M |
Free cash flow | 4,650.00%182M | -48.06%483M | -25.14%259M | -55.44%127M | -39.52%101M | -103.03%-4M | 73.83%930M | 35.16%346M | 71.69%285M | 34.68%167M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |